UniProt ID | VAV_HUMAN | |
---|---|---|
UniProt AC | P15498 | |
Protein Name | Proto-oncogene vav | |
Gene Name | VAV1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 845 | |
Subcellular Localization | ||
Protein Description | Couples tyrosine kinase signals with the activation of the Rho/Rac GTPases, thus leading to cell differentiation and/or proliferation.. | |
Protein Sequence | MELWRQCTHWLIQCRVLPPSHRVTWDGAQVCELAQALRDGVLLCQLLNNLLPHAINLREVNLRPQMSQFLCLKNIRTFLSTCCEKFGLKRSELFEAFDLFDVQDFGKVIYTLSALSWTPIAQNRGIMPFPTEEESVGDEDIYSGLSDQIDDTVEEDEDLYDCVENEEAEGDEIYEDLMRSEPVSMPPKMTEYDKRCCCLREIQQTEEKYTDTLGSIQQHFLKPLQRFLKPQDIEIIFINIEDLLRVHTHFLKEMKEALGTPGAANLYQVFIKYKERFLVYGRYCSQVESASKHLDRVAAAREDVQMKLEECSQRANNGRFTLRDLLMVPMQRVLKYHLLLQELVKHTQEAMEKENLRLALDAMRDLAQCVNEVKRDNETLRQITNFQLSIENLDQSLAHYGRPKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHSFQVRDDSSGDRDNKKWSHMFLLIEDQGAQGYELFFKTRELKKKWMEQFEMAISNIYPENATANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPPCGRHGQDFPGTMKKDKLHRRAQDKKRNELGLPKMEVFQEYYGLPPPPGAIGPFLRLNPGDIVELTKAEAEQNWWEGRNTSTNEIGWFPCNRVKPYVHGPPQDLSVHLWYAGPMERAGAESILANRSDGTFLVRQRVKDAAEFAISIKYNVEVKHIKIMTAEGLYRITEKKAFRGLTELVEFYQQNSLKDCFKSLDTTLQFPFKEPEKRTISRPAVGSTKYFGTAKARYDFCARDRSELSLKEGDIIKILNKKGQQGWWRGEIYGRVGWFPANYVEEDYSEYC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
67 | Phosphorylation | VNLRPQMSQFLCLKN HCCCHHHHHHHHHHH | 16.72 | 26546556 | |
73 | Ubiquitination | MSQFLCLKNIRTFLS HHHHHHHHHHHHHHH | 49.70 | - | |
85 | Ubiquitination | FLSTCCEKFGLKRSE HHHHHHHHHCCCHHH | 30.71 | - | |
89 | Ubiquitination | CCEKFGLKRSELFEA HHHHHCCCHHHHHHH | 55.01 | - | |
110 | Phosphorylation | QDFGKVIYTLSALSW HHHHHHHHHHHHCCC | 12.48 | 25147952 | |
113 | Phosphorylation | GKVIYTLSALSWTPI HHHHHHHHHCCCCCC | 21.26 | - | |
142 | Phosphorylation | SVGDEDIYSGLSDQI CCCCHHHHCCCHHHC | 14.70 | 10669745 | |
160 | Phosphorylation | VEEDEDLYDCVENEE CCCCCCHHHHHHCCC | 21.44 | 10669745 | |
174 | Phosphorylation | EAEGDEIYEDLMRSE CCCCCHHHHHHHHCC | 11.01 | 10636924 | |
180 | Phosphorylation | IYEDLMRSEPVSMPP HHHHHHHCCCCCCCC | 32.08 | 24275569 | |
188 | Ubiquitination | EPVSMPPKMTEYDKR CCCCCCCCCCHHHHH | 53.21 | - | |
192 | Phosphorylation | MPPKMTEYDKRCCCL CCCCCCHHHHHHCHH | 20.00 | - | |
194 | Acetylation | PKMTEYDKRCCCLRE CCCCHHHHHHCHHHH | 46.57 | 23749302 | |
194 | Ubiquitination | PKMTEYDKRCCCLRE CCCCHHHHHHCHHHH | 46.57 | - | |
208 | Ubiquitination | EIQQTEEKYTDTLGS HHHHHHHHHHHHHHH | 47.41 | - | |
212 | Phosphorylation | TEEKYTDTLGSIQQH HHHHHHHHHHHHHHH | 25.81 | 28450419 | |
215 | Phosphorylation | KYTDTLGSIQQHFLK HHHHHHHHHHHHHHH | 21.97 | 28450419 | |
220 | Acetylation | LGSIQQHFLKPLQRF HHHHHHHHHHHHHHH | 9.01 | 19608861 | |
222 | Ubiquitination | SIQQHFLKPLQRFLK HHHHHHHHHHHHHCC | 42.62 | 21890473 | |
222 | Ubiquitination | SIQQHFLKPLQRFLK HHHHHHHHHHHHHCC | 42.62 | 21906983 | |
222 | Acetylation | SIQQHFLKPLQRFLK HHHHHHHHHHHHHCC | 42.62 | 23749302 | |
252 | Acetylation | RVHTHFLKEMKEALG HHHHHHHHHHHHHHC | 55.61 | 19608861 | |
255 | Ubiquitination | THFLKEMKEALGTPG HHHHHHHHHHHCCCC | 40.71 | - | |
267 | Phosphorylation | TPGAANLYQVFIKYK CCCCHHHHHHHHHHH | 11.48 | 20090780 | |
272 | Ubiquitination | NLYQVFIKYKERFLV HHHHHHHHHHHHHHH | 38.51 | - | |
280 | Phosphorylation | YKERFLVYGRYCSQV HHHHHHHCCHHHHHH | 9.68 | 18083107 | |
283 | Phosphorylation | RFLVYGRYCSQVESA HHHHCCHHHHHHHHH | 7.65 | 26552605 | |
285 | Phosphorylation | LVYGRYCSQVESASK HHCCHHHHHHHHHHH | 28.46 | 26552605 | |
289 | Phosphorylation | RYCSQVESASKHLDR HHHHHHHHHHHHHHH | 38.70 | 26552605 | |
291 | Phosphorylation | CSQVESASKHLDRVA HHHHHHHHHHHHHHH | 29.86 | 26552605 | |
292 | Ubiquitination | SQVESASKHLDRVAA HHHHHHHHHHHHHHH | 48.15 | - | |
307 | Ubiquitination | AREDVQMKLEECSQR HHHHHHHHHHHHHHH | 35.34 | 21890473 | |
307 | Acetylation | AREDVQMKLEECSQR HHHHHHHHHHHHHHH | 35.34 | 25953088 | |
321 | Phosphorylation | RANNGRFTLRDLLMV HHHCCCCCHHHHHHH | 21.37 | 24719451 | |
335 | Ubiquitination | VPMQRVLKYHLLLQE HHHHHHHHHHHHHHH | 27.97 | 21890473 | |
345 | Ubiquitination | LLLQELVKHTQEAME HHHHHHHHHHHHHHH | 54.26 | - | |
345 | Acetylation | LLLQELVKHTQEAME HHHHHHHHHHHHHHH | 54.26 | 7374163 | |
353 | Ubiquitination | HTQEAMEKENLRLAL HHHHHHHHHHHHHHH | 38.53 | 21890473 | |
374 | Ubiquitination | AQCVNEVKRDNETLR HHHHHHHHCCHHHHH | 48.10 | 21890473 | |
396 | Phosphorylation | SIENLDQSLAHYGRP EEEHHHHHHHHHCCC | 27.47 | - | |
404 | Ubiquitination | LAHYGRPKIDGELKI HHHHCCCCCCCEEEE | 52.66 | - | |
410 | Ubiquitination | PKIDGELKITSVERR CCCCCEEEEEEHHHH | 39.37 | 21890473 | |
423 | Phosphorylation | RRSKMDRYAFLLDKA HHHCCHHHHHHHHHH | 9.46 | 28796482 | |
429 | Ubiquitination | RYAFLLDKALLICKR HHHHHHHHHHHHHHH | 40.69 | - | |
435 | Ubiquitination | DKALLICKRRGDSYD HHHHHHHHHCCCCCC | 37.83 | - | |
435 | Acetylation | DKALLICKRRGDSYD HHHHHHHHHCCCCCC | 37.83 | 25953088 | |
444 | Acetylation | RGDSYDLKDFVNLHS CCCCCCHHHHCEEEE | 46.34 | 25953088 | |
444 | Ubiquitination | RGDSYDLKDFVNLHS CCCCCCHHHHCEEEE | 46.34 | 21890473 | |
465 | Ubiquitination | SSGDRDNKKWSHMFL CCCCCCCCCEEEEEE | 60.97 | - | |
487 | Acetylation | QGYELFFKTRELKKK CCEEEEEEHHHHHHH | 39.06 | 30593339 | |
541 | Phosphorylation | MLLRGTFYQGYRCHR HHHHCCCCCCCCCCC | 10.81 | - | |
555 | Ubiquitination | RCRASAHKECLGRVP CCCHHHCHHHHCCCC | 50.25 | - | |
574 | Phosphorylation | HGQDFPGTMKKDKLH CCCCCCCCCCHHHHH | 26.51 | 30576142 | |
576 | Ubiquitination | QDFPGTMKKDKLHRR CCCCCCCCHHHHHHH | 58.62 | - | |
577 | Ubiquitination | DFPGTMKKDKLHRRA CCCCCCCHHHHHHHH | 49.63 | - | |
588 | Ubiquitination | HRRAQDKKRNELGLP HHHHHHHHHHCCCCC | 69.60 | - | |
603 | Phosphorylation | KMEVFQEYYGLPPPP HHHHHHHHHCCCCCC | 7.64 | - | |
629 | Ubiquitination | GDIVELTKAEAEQNW CCEEEECHHHHHHCC | 57.78 | - | |
683 | Phosphorylation | MERAGAESILANRSD HHHCCCHHHHCCCCC | 23.51 | 24670416 | |
684 | Acetylation | ERAGAESILANRSDG HHCCCHHHHCCCCCC | 2.95 | 19608861 | |
700 | Ubiquitination | FLVRQRVKDAAEFAI EEEEEHHHHHHHHHH | 43.78 | - | |
716 | Ubiquitination | IKYNVEVKHIKIMTA EEEEEEEEEEEEEEH | 26.55 | 19608861 | |
716 | Acetylation | IKYNVEVKHIKIMTA EEEEEEEEEEEEEEH | 26.55 | 19608861 | |
722 | Phosphorylation | VKHIKIMTAEGLYRI EEEEEEEEHHHHHHH | 25.65 | 29449344 | |
727 | Phosphorylation | IMTAEGLYRITEKKA EEEHHHHHHHHHHHH | 15.72 | 29449344 | |
732 | Ubiquitination | GLYRITEKKAFRGLT HHHHHHHHHHHCCHH | 40.53 | - | |
732 | Acetylation | GLYRITEKKAFRGLT HHHHHHHHHHHCCHH | 40.53 | 7306861 | |
733 | Acetylation | LYRITEKKAFRGLTE HHHHHHHHHHCCHHH | 46.67 | 7306871 | |
745 | Phosphorylation | LTELVEFYQQNSLKD HHHHHHHHHHCCHHH | 8.83 | 20028078 | |
751 | Ubiquitination | FYQQNSLKDCFKSLD HHHHCCHHHHHHHCC | 52.88 | 21890473 | |
755 | Ubiquitination | NSLKDCFKSLDTTLQ CCHHHHHHHCCCCCC | 57.34 | - | |
756 | Phosphorylation | SLKDCFKSLDTTLQF CHHHHHHHCCCCCCC | 15.95 | 30108239 | |
759 | Phosphorylation | DCFKSLDTTLQFPFK HHHHHCCCCCCCCCC | 34.40 | 30108239 | |
760 | Phosphorylation | CFKSLDTTLQFPFKE HHHHCCCCCCCCCCC | 20.44 | 30108239 | |
766 | Ubiquitination | TTLQFPFKEPEKRTI CCCCCCCCCCCCCCC | 73.01 | - | |
770 | Ubiquitination | FPFKEPEKRTISRPA CCCCCCCCCCCCCCC | 66.61 | - | |
774 | Phosphorylation | EPEKRTISRPAVGST CCCCCCCCCCCCCCC | 31.44 | - | |
780 | Phosphorylation | ISRPAVGSTKYFGTA CCCCCCCCCCCCCCC | 18.35 | 29978859 | |
781 | Phosphorylation | SRPAVGSTKYFGTAK CCCCCCCCCCCCCCH | 24.68 | 29978859 | |
782 | Acetylation | RPAVGSTKYFGTAKA CCCCCCCCCCCCCHH | 40.04 | 25953088 | |
782 | Ubiquitination | RPAVGSTKYFGTAKA CCCCCCCCCCCCCHH | 40.04 | - | |
783 | Phosphorylation | PAVGSTKYFGTAKAR CCCCCCCCCCCCHHH | 13.82 | - | |
786 | Phosphorylation | GSTKYFGTAKARYDF CCCCCCCCCHHHHEE | 18.32 | - | |
788 | Ubiquitination | TKYFGTAKARYDFCA CCCCCCCHHHHEECC | 32.98 | - | |
791 | Phosphorylation | FGTAKARYDFCARDR CCCCHHHHEECCCCC | 20.45 | 25147952 | |
799 | Phosphorylation | DFCARDRSELSLKEG EECCCCCCCCCCCCC | 47.37 | 30108239 | |
802 | Phosphorylation | ARDRSELSLKEGDII CCCCCCCCCCCCCEE | 33.09 | 30108239 | |
804 | Ubiquitination | DRSELSLKEGDIIKI CCCCCCCCCCCEEEE | 57.16 | - | |
810 | Ubiquitination | LKEGDIIKILNKKGQ CCCCCEEEEEECCCC | 41.28 | - | |
815 | Ubiquitination | IIKILNKKGQQGWWR EEEEEECCCCCCEEC | 61.96 | - | |
826 | Phosphorylation | GWWRGEIYGRVGWFP CEECCEEECEECCEE | 8.45 | 30576142 | |
836 | Phosphorylation | VGWFPANYVEEDYSE ECCEEHHHCCCCHHH | 16.02 | 26552605 | |
841 | Phosphorylation | ANYVEEDYSEYC--- HHHCCCCHHHHC--- | 13.49 | 28796482 | |
842 | Phosphorylation | NYVEEDYSEYC---- HHCCCCHHHHC---- | 34.12 | 28796482 | |
844 | Phosphorylation | VEEDYSEYC------ CCCCHHHHC------ | 9.49 | 19605366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
142 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
160 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
174 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
174 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
267 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:11087752 |
- | K | Ubiquitination | E3 ubiquitin ligase | SOCS1 | O15524 | PMID:10747851 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VAV_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VAV_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-222; LYS-252 AND LYS-716,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-826, AND MASSSPECTROMETRY. |